Brain tumor study aims to unlock immune secrets after surgery
NCT ID NCT07568782
First seen May 14, 2026 · Last updated May 22, 2026 · Updated 2 times
Summary
This study looks at how the immune system changes in people with glioblastoma, a serious brain cancer, after they have surgery and chemoradiotherapy. Researchers will take blood samples over six months to measure immune cells and signals. The goal is to understand the body's immune response to standard treatment, which may help improve future therapies. About 17 adults with suspected glioblastoma will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Lille
Lille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.